Straetemans T - Search Results

1

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu.

Kunert A, Straetemans T, Govers C, Lamers C, Mathijssen R, Sleijfer S, Debets R. Kunert A, et al. Among authors: straetemans t. Front Immunol. 2013 Nov 8;4:363. doi: 10.3389/fimmu.2013.00363. eCollection 2013. Front Immunol. 2013. PMID: 24265631 Free PMC article. Review.

2

T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies.

Coccoris M, Straetemans T, Govers C, Lamers C, Sleijfer S, Debets R. Coccoris M, et al. Among authors: straetemans t. Expert Opin Biol Ther. 2010 Apr;10(4):547-62. doi: 10.1517/14712591003614756. Expert Opin Biol Ther. 2010. PMID: 20146634 Review.

3

T-cell receptor gene therapy in human melanoma-bearing immune-deficient mice: human but not mouse T cells recapitulate outcome of clinical studies.

Straetemans T, Coccoris M, Berrevoets C, Treffers-Westerlaken E, Scholten CE, Schipper D, Ten Hagen TL, Debets R. Straetemans T, et al. Hum Gene Ther. 2012 Feb;23(2):187-201. doi: 10.1089/hum.2010.126. Epub 2011 Dec 2. Hum Gene Ther. 2012. PMID: 21958294

4

TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.

Straetemans T, van Brakel M, van Steenbergen S, Broertjes M, Drexhage J, Hegmans J, Lambrecht BN, Lamers C, van Der Bruggen P, Coulie PG, Debets R. Straetemans T, et al. Clin Dev Immunol. 2012;2012:586314. doi: 10.1155/2012/586314. Epub 2012 Feb 12. Clin Dev Immunol. 2012. PMID: 22400038 Free PMC article.

5

Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment.

Straetemans T, Berrevoets C, Coccoris M, Treffers-Westerlaken E, Wijers R, Cole DK, Dardalhon V, Sewell AK, Taylor N, Verweij J, Debets R. Straetemans T, et al. Mol Ther. 2015 Feb;23(2):396-406. doi: 10.1038/mt.2014.215. Epub 2014 Nov 3. Mol Ther. 2015. PMID: 25363716 Free PMC article.

6

GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR.

Straetemans T, Kierkels GJJ, Doorn R, Jansen K, Heijhuurs S, Dos Santos JM, van Muyden ADD, Vie H, Clemenceau B, Raymakers R, de Witte M, Sebestyén Z, Kuball J. Straetemans T, et al. Front Immunol. 2018 May 30;9:1062. doi: 10.3389/fimmu.2018.01062. eCollection 2018. Front Immunol. 2018. PMID: 29899740 Free PMC article.

7

Adding Help to an HLA-A*24:02 Tumor-Reactive γδTCR Increases Tumor Control.

Johanna I, Hernández-López P, Heijhuurs S, Scheper W, Bongiovanni L, de Bruin A, Beringer DX, Oostvogels R, Straetemans T, Sebestyen Z, Kuball J. Johanna I, et al. Among authors: straetemans t. Front Immunol. 2021 Oct 25;12:752699. doi: 10.3389/fimmu.2021.752699. eCollection 2021. Front Immunol. 2021. PMID: 34759930 Free PMC article.

8

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies.

Meringa AD, Hernández-López P, Cleven A, de Witte M, Straetemans T, Kuball J, Beringer DX, Sebestyen Z. Meringa AD, et al. Among authors: straetemans t. Front Immunol. 2023 Jun 27;14:1159337. doi: 10.3389/fimmu.2023.1159337. eCollection 2023. Front Immunol. 2023. PMID: 37441064 Free PMC article. No abstract available.

9

γδ T-cell Receptors Derived from Breast Cancer-Infiltrating T Lymphocytes Mediate Antitumor Reactivity.

Janssen A, Villacorta Hidalgo J, Beringer DX, van Dooremalen S, Fernando F, van Diest E, Terrizi AR, Bronsert P, Kock S, Schmitt-Gräff A, Werner M, Heise K, Follo M, Straetemans T, Sebestyen Z, Chudakov DM, Kasatskaya SA, Frenkel FE, Ravens S, Spierings E, Prinz I, Küppers R, Malkovsky M, Fisch P, Kuball J. Janssen A, et al. Among authors: straetemans t. Cancer Immunol Res. 2020 Apr;8(4):530-543. doi: 10.1158/2326-6066.CIR-19-0513. Epub 2020 Feb 4. Cancer Immunol Res. 2020. PMID: 32019779

10

γ9δ2 T-Cell Expansion and Phenotypic Profile Are Reflected in the CDR3δ Repertoire of Healthy Adults.

Vyborova A, Janssen A, Gatti L, Karaiskaki F, Yonika A, van Dooremalen S, Sanders J, Beringer DX, Straetemans T, Sebestyen Z, Kuball J. Vyborova A, et al. Among authors: straetemans t. Front Immunol. 2022 Jul 7;13:915366. doi: 10.3389/fimmu.2022.915366. eCollection 2022. Front Immunol. 2022. PMID: 35874769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters